Tamsulosin HCL SR Pellets 0.125%, 0.2%

₹ 2,960 - ₹ 5,000 / kg

Country of OriginIndia
MOQ200kg
USPtest 4, test 6
Supply TypeManufacturer, Exporter, Supplier
Preferred Buyer Location All over the world

Release pattern compared with innovator Flomax. MKPPL objective is to develop Tamsulosin hydrochloride SR pellets by aqueous phase and pellets developed by aqueous technology had better advantage....

Company Information

Member Since 13 Years
Nature of Business Manufacturer
Year of Establishment 2004

Ask for more detail from the seller

Report incorrect details

Product Details
Company Details

Release pattern compared with innovator Flomax.
MKPPL objective is to develop Tamsulosin hydrochloride SR pellets by aqueous phase and pellets developed by aqueous technology had better advantage of avoiding the use of organic solvents.
In case of fluid bed coater, to achieve the desired sustained release profile equivalent to innovator, MKPPL drug loaded pellets will be coated with polymers, either single polymer or in combination with different ratios.
In case of extrusion Spheronization, Tamsulosin hydrochloride SR pellets can be develop by preparing wet mass of API & Excipients.
Offer complete technical package for registrations in all regulated/semi regulated markets.

Percentage:0.12%, 0.13%, 0.16%, 0.20%,Release Type:Extended Release, Target Formulations:Capsules,Documentation Available:DMF in CTD Format.